首页> 外文期刊>Southern Medical Journal >Sex-specific substance abuse treatment for female healthcare professionals: Implications
【24h】

Sex-specific substance abuse treatment for female healthcare professionals: Implications

机译:女性医疗保健专业人士的性别特异性药物滥用治疗:含义

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Gender plays a significant role in the development and treatment of substance abuse disorders. Sex-specific treatment for girls and women has recurrently proven more effective, with better outcomes than traditional treatment. Research on impaired healthcare professionals (HCPs) has largely focused on men, garnering little attention for women and sex differences. With the increasing numbers of female HCPs, it is imperative to identify potential sex differences that may have implications for treatment. Our study compared a convenience sample of male and female HCPs with substance abuse disorders treated in an outpatient program to identify sex differences that may have implications for treatment. METHODS: Our sample consisted of 96 HCPs (54 men, 42 women) and 17 non-healthcare professional (N-HCP) women. All of the participants were evaluated using the program's clinical interview and the Personality Assessment Inventory (PAI). Chart review data contained categorical variables, qualitative variables, diagnoses, and psychological test scores. A second analysis was conducted through two separate comparisons: the PAI results of comparing impaired female HCPs with impaired male HCPs and the PAI results of comparing impaired female HCPs with impaired female N-HCPs. RESULTS: Statistically significant differences indicated more male participants received prior treatment and more intensive treatment than female participants. More female subjects reported being diagnosed as having a comorbid psychiatric condition and taking psychotropic medications. Several statistically significant differences in the PAI scores were found. Among female HCPs, elevations were found in anxiety, depression, paranoia, and borderline personality disorder. Substantive differences, although not statistically significant, were elevations in somatic complaints and anxiety disorders in female HCPs. In the comparison of female HCPs and N-HCPs, the only statistically significant difference was the significantly higher anxiety score of N-HCPs. CONCLUSIONS: The results indicate greater differences between female HCPs and male HCPs than between female HCPs and N-HCPs.
机译:目标:性别在制定和治疗物质滥用障碍方面发挥着重要作用。儿童和女性的性别特异性治疗经过常规证明更有效,具有比传统治疗更好的结果。对医疗保健专业人士(HCP)的研究在很大程度上专注于男性,为妇女和性别差异施加着一点。随着越来越多的雌性HCP,必须识别可能对治疗影响有影响的潜在性差异。我们的研究比较了男性和女性HCP的便利样本,在门诊计划中治疗的药物滥用疾病,以识别可能对治疗有影以来影响的性差异。方法:我们的样品由96个HCP(54名男子,42名女性)和17名非医疗保健专业(N-HCP)女性组成。所有参与者都是使用该计划的临床访谈和人格评估库存(PAI)进行评估。图表审查数据包含分类变量,定性变量,诊断和心理测试分数。通过两个单独的比较进行第二分析:PAI结果与雄性HCP受损的患者HCP进行了比较,并且对雌性N-HCP受损的患者HCP进行了比较的PAI结果。结果:统计上显着的差异表明,更多的男性参与者接受了先前治疗和比女性参与者更强烈的治疗。更多的女性受试者报告被诊断为具有合并症的精神病病症并服用精神药物。发现了PAI评分的几种统计学意义差异。在雌性HCP中,焦虑,抑郁症,偏执象和边缘人格障碍中发现了升高。实质性差异虽然没有统计学意义,但在雌性HCP中的躯体投诉和焦虑症中的升高。在雌性HCP和N-HCP的比较中,唯一的统计学意义差异是N-HCP的显着焦虑评分。结论:结果表明雌性HCP和雄性HCP之间的差异比雌性HCP和N-HCP之间的较大差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号